bsAb
-
The biggest biotech financing of the year has been born! Who will be the next “buyer”?
What will be the fate of this new player in autoimmune diseases in the future?
-
8 Key Highlights! What Do Global Pharma Industry BD and M&A Trends Forecast for 2024?
Where Pharma is Investing for the Future of Medicine: Biopharma Deal Making in 2024
-
【Product for Licensing】CLDN6 X 4-1BB bispecific antibody
If interested, please contact DrugTimes BD Team at BD@drugtimes.cn. Many thanks!
-
中国双特异性抗体的开发概况与展望
谈起中国新药研发中的热点，双特异性抗体这一“后浪”必然榜上有名。药时代一直在密切关注，进行了系列分享。 连环画 | 双特异性抗体 重磅！为何信达和罗氏对双特异性抗体痴心不改 控…
